Filing Details
- Accession Number:
- 0001728117-24-000073
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-20 20:21:38
- Reporting Period:
- 2024-06-18
- Accepted Time:
- 2024-06-20 20:21:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1728117 | Gossamer Bio Inc. | GOSS | Pharmaceutical Preparations (2834) | 475461709 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1740847 | Bryan Giraudo | 3013 Science Park Road San Diego CA 92121 | Coo/Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-06-18 | 100,000 | $0.59 | 480,010 | No | 4 | P | Indirect | By family trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By family trust |
Footnotes
- The Reporting Person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 6,430 shares, with the Reporting Person's sale of 6,430 shares of common stock at a price of $1.1556 per share on March 27, 2024. The reporting person has agreed to pay to the Issuer $3,653.10, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
Billionaire Hedge Funds
